Loading...
Images of Øystein Rekdal
(0 from 0 )1
0
0
News
nrk.no: Ny medisin mot kreft og bakterier – NRK Viten – Nyheter innen...
To norske forskere, John Sigurd Svendsen og Øystein Rekdal ved Universitetet i Tromsø, står foran det store gjennombruddet. De har utviklet en ny medisin som...
Read more News Detail - Lytix Biopharmawww.lytixbiopharma.com › news › Lytix-Biopharma-AS-appoints-Øy...
www.lytixbiopharma.com
The board has decided to promote Head of R&D Øystein Rekdal to the position of CEO from September 11, Dr. Klumper has agreed to ...
Day of Immunology Conference April 29 Immunotherapy ...www.ous-research.no › home › institute › news
www.ous-research.no
Øystein Rekdal, PhD, Professor, The Arctic University of Norway, CSO, Lytix Biopharma AS. Meeting's organizers: The Norwegian Society for Immunology (NSI).
Telephone & Addresses
1881: Øystein RekdalSlependen, Asker nowww no › person › asker › slependen
Se hvem som ringer! Prøv vår app gratis i 30 dager. Send blomster til Øystein Rekdal; Se hva Grensefaret 24 ble solgt for og tidligere eiere – Eiendomspriser.no ...
gulesider: Øystein Rekdal | personer | gulesider.nowww.gulesider.no › øystein+rekdal › personer
Kontaktinformasjon for Øystein Rekdal, telefonnummer, adresse og mer kontaktinformasjon.
Network Profiles
LinkedIn: Øystein Rekdal | LinkedIn
LinkedIn er verdens største forretningsnettverk, og hjelper fagpersoner som Øystein Rekdal med å finne innsideforbindelser som kan anbefale kandidater, ...
LinkedIn: Øystein Rekdal | LinkedIn
Se på Øystein Rekdals (Norge) profil på LinkedIn. LinkedIn er verdens største forretningsnettverk, og hjelper fagpersoner slik som Øystein Rekdal med å finne ...
Interests
Antiviral Research (v.61, #2) | www.chemweb.com
www.chemweb.com
... to their affinity for heparan sulfate by Håvard Jenssen; Jeanette Hammer Andersen; Lars Uhlin-Hansen; Tore Jarl Gutteberg; Øystein Rekdal ( ).
John Sigurd Svendsen - Patent Inventor
www.freshpatents.com
List of recent John Sigurd Svendsen patent applications
Structure-Function Analysis of Tritrpticin Analogs ...
www.cell.com
Structure-Function Analysis of Tritrpticin Analogs: Potential Relationships between Antimicrobial Activities, ... Øystein Rekdal. Search for articles by this author
Sign In - Journal of Biological Chemistry
www.jbc.org
Øystein Rekdal, Bengt Erik Haug, Manar Kalaaji, Howard N. Hunter, Inger Lindin, Ingrid Israelsson, Terese Solstad, Nannan Yang, Martin Brandl, Dimitrios Mantzilas,
Management & Stakeholders
proff: Øystein Rekdal – 1 roller i norsk næringsliv - Proffwww.proff.no › ... › Anbud › Segmentering
Proff.no gir deg rolleinformasjon om Øystein Rekdal. Se hans roller (1) og relasjoner (3) i næringslivet - og hvilke bransjer Øystein Rekdal er aktiv i.
Oystein Rekdal - MarketVisual Knowledge Map
www.marketvisual.com
New Search: Oystein Rekdal. Oystein Rekdal. Knowledge Map Preview. Company Affiliations. Company, # of Roles. Lytix Biopharma AS, 2. Current Affiliations.
Lytix Biopharma AS - MarketVisual Knowledge Map
www.marketvisual.com
Map Øystein Rekdal and Lytix Biopharma AS's 2 relationships. Map Anders Fugelli and Lytix Biopharma AS's 2 relationships ...
Business Profiles
Researchgate: Øystein Rekdal
Tromsø, Norway
patentbuddy: Øystein Rekdal
LYTIX BIOPHARMA AS, Tomasjord, NO
Oystein Rekdal - Co-Founder & CSO @ Lytix Biopharma ...www.crunchbase.com › person › oystein-rekdal
www.crunchbase.com
Øystein Rekdal served as the CEO of Lytix Biopharma since the establishment in He currently leads the company-internal research programmes in support of the near- and mid-term pipeline. Dr. Rekdal received his PhD from the University of Tromsø.
Books & Literature
Construction and synthesis of lactoferricin derivatives with enhanced...
onlinelibrary.wiley.com
Øystein Rekdal, Institute of Medical Biology, Faculty of Medicine, University of Tromsø, Tromsø, Norway; Search for more papers by this author. Jill Andersen,
AACR 2016: Abstracts American Association for Cancer...
books.google.de
The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...
AACR 2016: Abstracts Google Books Resultbooks.google.com › books
books.google.com
Takahiro Yamazaki,1 Marie Vetizou,1 Camila Flores,1 Aurelien Marabelle,1 Baldur Sveinbjørnsson,2 Øystein Rekdal, 2 Guido Kroemer,1 Laurence Zitvogel1.
AACR Proceedings: Abstracts American Association for...
books.google.de
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their...
Related Documents
Exploring the potential of innate immunity for developing ...
uit.no
Exploring the potential of innate immunity for developing antimicrobial drugs . Tromsø – 27th September Vorland, Øystein Rekdal and John S. Mjøen
Bjarne Østerud BIRTH: July 23, l940 ADDRESS - eriktysse.com
www.eriktysse.com
Charlotte Sissener Engstad, Øystein Rekdal, Jan Ole Olsen and Bjarne Østerud. A ... Liv Tone Eliassen, Øystein Rekdal, John Sigurd Svendsen and Bjarne ...
EBSCOhost | | Complete regression and systemic protective...
web.b.ebscohost.com
Chandra Sekhar Ravuri · Øystein Rekdal ·. Baldur Sveinbjørnsson received: 15 July accepted: 13 March Published online:
Scientific Publications
Small lytic peptides escape the inhibitory effect of heparan sulfate...
bmccancer.biomedcentral.com
BMC Cancer. Main menu Home; About; Articles; Submission Guidelines; Research article ... Øystein Rekdal 1, 3; BMC Cancer :116. DOI: …
Small lytic peptides escape the inhibitory effect of heparan sulfate...
www.ncbi.nlm.nih.gov
Bodil Fadnes: bodil.i.fadnes/at/uit.no; Lars Uhlin-Hansen: lars.uhlin.hansen/at/unn.no; Inger Lindin: inger.lindin/at/uit.no; Øystein Rekdal: ...
The anticancer activity of lytic peptides is inhibited by heparan...
www.ncbi.nlm.nih.gov
Bodil Fadnes,1,2 Øystein Rekdal,1,4 and Lars Uhlin-Hansen2, Bodil Fadnes: bodilf/at/fagmed.uit.no; Øystein Rekdal: oysteinr/at/fagmed.uit.no; Lars Uhlin-Hansen: lars. ...
Publications
Publications Authored by Oystein Rekdal | …
www.pubfacts.com
Are you Oystein Rekdal? Register this Author. 32Publications-Reads. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. Authors:
Complete regression and systemic protective immune responses obtained...
link.springer.com
Malignant melanoma is the most aggressive and deadliest form of skin cancer due to its highly metastatic potential, which calls for new and improved therap
Lytix Raises $9 Million in Private Placement. - Free Online Library
www.thefreelibrary.com
Free Online Library: Lytix Raises $9 Million in Private Placement. by
Small lytic peptides escape the inhibitory effect of heparan sulfate...
link.springer.com
(1) (3); Øystein Rekdal · (1) (3). Author Affiliations. 1. Institute of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, ...
Reports & Statements
Twitter Posts: [iito] Life Science on Twitter: "Lytix Biopharma AS appoints ...twitter.com › iitoLifeScience › status
... follow request to @iitoLifeScience. More. Copy link to Tweet; Embed Tweet. Lytix Biopharma AS appoints Øystein Rekdal as the new CEO ...
Google Blogs: Lytix-Peptide Kill Cancer Cells and Multi-Resistant Bacteria ...
The Norwegian professors John Sigurd Svendsen of organic chemistry and Øystein Rekdal of biochemistry has started human testing with the Lytix-peptide. It's a molecule found in colostrum, which has shown to have potential both as an ...
Oncolysis with DTT-205 and DTT-304 generates Naturewww.nature.com › nature › cell death & disease › articles
www.nature.com
Brynjar Mauseth; , Baldur Sveinbjørnsson; & Øystein Rekdal. Division of Cancer, Surgery and Transplantation, Oslo University Hospital, ...
Miscellaneous
Øystein Rekdal | LinkedIn
www.linkedin.com
View Øystein Rekdal’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Øystein Rekdal discover ...
Øystein Rekdal - R&D Director - Lytix Biopharma | …
www.linkedin.com
View Øystein Rekdal’s profile on LinkedIn, the world's largest professional community. Øystein has 1 job listed on their profile. See the complete profile on LinkedIn and discover Øystein’s connections and jobs at ...
WO A1 - Anti-lymphoma peptides - Google Patentswww.google.com › patents
www.google.com
Application number: PCT/EP ; Other languages: English (en) · French (fr); Inventor: John Sigurd Svendsen: Øystein REKDAL: Johannes EKSTEEN ...
WO A1 - A nonapeptide with anti-tumour activity
patents.google.com
The present invention relates to peptides or peptide like molecules and their uses in therapy, in particular as anti-tumour agents.
WO A1 - Treatment of biofilms Google Patents
patents.google.com
Inventors, Wenche Stensen, Frederick Alan Leeson, Stig Olov Magnus Engqvist, Trond Flaegstad, Øystein REKDAL, John Sigurd Svendsen.
Oystein Rekdal Ph.D.: Executive Profile & Biography ...www.bloomberg.com › research › stocks › people › person
www.bloomberg.com
Dr. Øystein Rekdal, Phd co-founded Lytix Biopharma AS in and has been its Chief Scientific Officer since April 25, Dr. Rekdal served as Chief ...
CCBIO seminar: Øystein Rekdal | The Department of ...www.uib.no › biomedisin › ccbio-seminar-øystein-rekdal
www.uib.no
From bench to bedside with a first in class oncolytic peptide. Øystein Rekdal Lytix Biopharma AS, Oslo, and Department of Medical Biology, The ...
WO A2 - Methods of peptide modification Google...
patents.google.com
Inventors, Wenche Stensen, Oystein Rekdal, John Sigurd Svendsen. Applicant, Lytix Biopharma As, Gardner Rebecca, Wenche Stensen, ...
Øystein Rekdal - Telefonkatalog fra no
telefonkatalog.1885.no
Øystein Rekdal er en mann registrert med Han bor i Sykehusvegen 23, Tromsø. Tromsø er i Tromsø kommune som er en del ...
Cristin
wo.cristin.no
Øystein Rekdal. Forskningsgruppe for molekylær inflammasjon (Professor ii) - UiT - Norges arktiske universitet. Kontaktinfo. UiT - Norges arktiske universitet.
Rekdal, Øystein | UiTuit.no › target
uit.no
Rekdal, Øystein. Professor. Molekylær inflammasjon forskningsgruppe (MIRG). · Tromsø · Legg visittkort i kontaktlisten din (vcard) ...
Oystein Rekdal - Co-Founder, Professor of Biotechnology in ...www.emedevents.com › speaker-profile › oystein-rekdal
www.emedevents.com
Biography : This section has yet to be updated by the speaker. Email: **********************. Contact : *** ** ** ** **. Social Media Info : This section has yet to be ...
Abstract 2589: In vitro activities of the cationic antitumoral...
cancerres.aacrjournals.org
In vitro activities of the cationic antitumoral peptide LTX Øystein Rekdal, ... In vitro activities of the cationic antitumoral peptide LTX-315 against ...
Abstract 477: Long-term protection against B16F1 melanoma upon...
cancerres.aacrjournals.org
... Øystein Rekdal, Ali Areffard. Long-term protection against B16F1 melanoma upon vaccination with tumor cell lysate combined with LTX-315 as a novel adjuvant.
Management Team - Lytix Biopharma
lytixbiopharma.com
Øystein Rekdal, PhD, Head R&D and CSO. Employed since Dr. Rekdal is co-founder of Lytix Biopharma and has extensive research background within tumor immunology, oncolytic peptides and their abilities to induce potent ...
The oncolytic peptide LTX-315 induces cell death …
www.sigmaaldrich.com
· Oncotarget The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells. [Liv-Marie Eike, Nannan Yang, Øystein Rekdal, Baldur Sveinbjørnsson] PMID
patentsgazette.uspto.gov
Wenche Stensen, Kvaloysletta (NO); Frederick Alan Leeson, Tromso (NO); Øystein Rekdal, Tromso (NO); and John Sigurd Svendsen, Kvaloysletta (NO).
Abstract 2326: LTX-315, an oncolytic peptide, increases anticancer...
cancerres.aacrjournals.org
Takahiro Yamazaki, Marie Vetizou, Camila Flores, Aurelien Marabelle, Baldur Sveinbjørnsson, Øystein Rekdal, Guido Kroemer, Laurence ...
Alta-mann bak vidundermedisin - Altaposten.no
www.altaposten.no
Professor John Sigurd Mjøen Svendsen og hans kolleger i Tromsø nærmer seg en vidundermedisin mot kreft og multiresistente bakterier.
Related search requests for Øystein Rekdal
| Edwin Klumper |
People Forename "Øystein" (1318) Name "Rekdal" (218) |
sorted by relevance / date